A major goal of the Immunology Core is to provide relevant immunologic assays and reagents for basic and clinical investigations of HIV and AIDS. This Core furthers understanding of the immunopathogenesis and pathogenesis of HIV infection and AIDS, provides new approaches toward understanding cellular and humoral responses to HIV, determines the effects of different anti-retroviral regimens on reconstitution of immunologic responses in HIV-infected subjects, determines the effects of immunotherapy or gene therapy on reconstitution of immunologic responses or on altering the clinical course in HIV-infected subjects receiving antiretroviral therapy, and develops HIV vaccine strategies. The Immunology Core (IC) offers a wide range of services to benefit all CFAR members performing H/V-related immunological research. Our services can be subdivided into two major groups: Self and Full Service. The self-service section of the Core prepares validated reagents and materials that are widely used among the member labs of the CFAR. These services include purification of primary human blood cells and antibody production, purification, labeling and enzymatic digestion. During the course of this application, the IC will create HIV-specific tetramer reagents. In addition, training is available for culture and transfection of primary cells, ELISA, and ELISPOT assays. The Full Service section will perform standard immunological assays using AACTG and PACTG approved protocols on samples provided by CFAR members. In addition, a number of flow cytometry-based assays including phenotyping, intracellular cytokine measurements and live sorting of both infectious and non-infectious materials can be performed by highly experienced technicians using the state-of-art equipment.
| Crits-Christoph, Paul; Gallop, Robert; Noll, Elizabeth et al. (2018) Impact of a medical home model on costs and utilization among comorbid HIV-positive Medicaid patients. Am J Manag Care 24:368-375 |
| Sherrill-Mix, Scott; McCormick, Kevin; Lauder, Abigail et al. (2018) Allometry and Ecology of the Bilaterian Gut Microbiome. MBio 9: |
| Kadimisetty, Karteek; Song, Jinzhao; Doto, Aoife M et al. (2018) Fully 3D printed integrated reactor array for point-of-care molecular diagnostics. Biosens Bioelectron 109:156-163 |
| Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459 |
| Fraietta, Joseph A; Nobles, Christopher L; Sammons, Morgan A et al. (2018) Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558:307-312 |
| Kelly, Matthew S; Surette, Michael G; Smieja, Marek et al. (2018) Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana. Pediatr Infect Dis J 37:1176-1183 |
| Chitre, Avantika S; Kattah, Michael G; Rosli, Yenny Y et al. (2018) A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function. PLoS Pathog 14:e1006806 |
| Milligan, Michael G; Bigger, Elizabeth; Abramson, Jeremy S et al. (2018) Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana. J Glob Oncol :1-11 |
| Medvec, Andrew R; Ecker, Christopher; Kong, Hong et al. (2018) Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium. Mol Ther Methods Clin Dev 8:65-74 |
| Washio, Yukiko; Novack Wright, Elizabeth; Davis-Vogel, Annet et al. (2018) Prior Exposure to Intimate Partner Violence Associated With Less HIV Testing Among Young Women. J Interpers Violence :886260518768564 |
Showing the most recent 10 out of 775 publications
